An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

C. L. Meinert

doi:10.1016/0197-2456(95)00257-X

An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

C. L. Meinert

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	273-284
Number of pages	12
Journal	Controlled clinical trials
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/0197-2456(95)00257-X
State	Published - 1996

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/0197-2456(95)00257-X

Cite this

@article{ce11f77b39f043668627a319852c4a78,

title = "An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy",

author = "Meinert, {C. L.}",

year = "1996",

doi = "10.1016/0197-2456(95)00257-X",

language = "English (US)",

volume = "17",

pages = "273--284",

journal = "Controlled clinical trials",

issn = "0197-2456",

publisher = "Elsevier BV",

number = "4",

}

TY - JOUR

T1 - An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

AU - Meinert, C. L.

PY - 1996

Y1 - 1996

UR - http://www.scopus.com/inward/record.url?scp=0029843341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029843341&partnerID=8YFLogxK

U2 - 10.1016/0197-2456(95)00257-X

DO - 10.1016/0197-2456(95)00257-X

M3 - Article

C2 - 8889342

AN - SCOPUS:0029843341

SN - 0197-2456

VL - 17

SP - 273

EP - 284

JO - Controlled clinical trials

JF - Controlled clinical trials

IS - 4

ER -

An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this